Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kunal S Jhaveri
Observed names:
Dr. Kunal Jhaveri,
Jhaveri, Kunal,
KUNAL JHAVERI,
Kunal Jhaveri,
Kunal S. Jhaveri
Institution:
Zydus Lifesciences Limited (India)
Observed institutions:
Nil Ratan Sircar Medical College and Hospital,
AstraZeneca (India),
Zydus Lifesciences Limited (India),
Medical College and Hospital, Kolkata
ORCID:
0009-0008-5582-9576
Observed ORCID:
0009-0008-5582-9576
OpenAlex ID:
A5108914691
Prevalence, pattern and perceptions of self-medication in medical students
2013
·
Rushi Pandya
, Kunal Jhaveri
, et al.
·
International Journal of Basic & Clinical Pharmacology
·
74
PDF
Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study)
2025
·
Viswanathan Mohan
, Shashank Joshi
, et al.
·
Diabetes Therapy
·
33
PDF
Evaluation of Effectiveness and Tolerability of Saroglitazar in Metabolic Disease Patients of India: A Retrospective, Observational, Electronic Medical Record-Based Real-World Evidence Study
2025
·
Sambit Das
, Sunil Gupta
, et al.
·
Cureus
·
6
PDF
Real-World Assessment of Personalized Approach With Voglibose Fixed-Dose Combination in Type 2 Diabetes Mellitus
2024
·
Nirmal Parmar
, Ajay Kumar Gupta
, et al.
·
Cureus
·
4
PDF
Efficacy of Fixed-dose Combination of Dapagliflozin and Sitagliptin in Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring: A Real-world Study in India
2023
·
Supratik Bhattacharyya
, Sameer Muchhala
, et al.
·
Journal of Advances in Medical and Pharmaceutical Sciences
·
3
PDF
A Cross-Sectional Study to Evaluate the Prevalence and Distribution of MASLD using Vibration-Controlled Transient Elastography in the General Population
2025
·
Gaurav Chhaya
, Kunal Jhaveri
, et al.
·
Journal of Diabetology
·
2
Prevalence of Clinically Significant Liver Fibrosis as Measured by Transient Elastography due to Non-alcoholic Fatty Liver Disease in Indian individuals with Type 2 Diabetes Mellitus
2024
·
Rajat Deb
, Soumik Goswami
, et al.
·
Indian Journal of Endocrinology and Metabolism
·
2
Real World Evidence of Bempedoic Acid on Efficacy and Safety in Patients with Uncontrolled LDL-c and at High Risk of CVD
2023
·
S. Manoj
, Jay Shah
, et al.
·
Cardiology and Angiology An International Journal
·
2
PDF
Real-world-evidence, prospective-observational study to evaluate safety and effectiveness of rabeprazole dual-delayed-release capsules in patients with gastroesophageal reflux disease
2025
·
Parimal Lawate
, Virender Chauhan
, et al.
·
World Journal of Gastrointestinal Pharmacology and Therapeutics
·
1
Knowledge-Attitude-Practices of Non-Alcoholic Fatty Liver Disease among Indian Patients with metabolic disorders: A Multi-centric Cross-Sectional Observational Study
2024
·
Dr. Shehla Shaikh
, Dr. Vijay Negalur
, et al.
·
International Journal Of Medical Science And Clinical Invention
·
1
PDF
Cardiometabolic Efficacy and Renal Safety of Saroglitazar in Indian Patients with Type 2 Diabetes — a 36-Month Retrospective Observational Study
2026
·
Gaurav Chhaya
, Kunal Jhaveri
, et al.
·
Clinical Diabetology
PDF
24-PUB: Effectiveness and Safety of Saroglitazar on Hypertriglyceridemia and Glycemic Parameters in Type 2 Diabetes with Comorbidities: Six-Month Study in India (LEAD INDIA-V)
2026
·
BALAJI JAGANMOHAN
, PRIYANKA K
, et al.
·
Diabetes
Effectiveness and Safety of Saroglitazar in Patients With Metabolic Disease in India Stratified by Estimated Glomerular Filtration Rate (eGFR): A Retrospective, Observational, Electronic Medical Record (EMR)-Based Real-World Evidence Study
2026
·
Kamlakar Tripathi
, Deodatta Chafekar
, et al.
·
Cureus
PDF
Effectiveness and Tolerability of Saroglitazar in Metabolic Disease Patients of India Stratified by estimated glomerular filtration rate: A Retrospective, Observational, Real-World Evidence Study.
2025
·
Vinodhini Ranganathan Mudaliyar
, Kunal Jhaveri
·
Indian Heart Journal
Response to: Letter to the Editor Regarding ‘Profile of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study)’
2025
·
Viswanathan Mohan
, Kunal Jhaveri
·
Diabetes Therapy
PDF
Domiciliary Management of Ischaemic Heart Disease of the Patients Not willing for Invasive Treatment: A Pilot Study from India
2025
·
Vineet Jagnany
, Anand Jagnany
, et al.
·
Preventive Medicine Research & Reviews
Studying how safe and effective deriphyllin is for treating breathing problems in real-life settings across multiple hospitals
2025
·
Kunal Jhaveri
, Prachi Sharma
·
http://isrctn.com/
Impact of Saroglitazar on the Metabolic Profile in Type 2 Diabetes Mellitus Patients with Moderate to Severe Hypertriglyceridemia
2024
·
Shefali Karkhanis
, Ami Sanghvi
, et al.
·
Journal of Advances in Medicine and Medical Research
Impact of Saroglitazar as an Add-on Therapy to Rosuvastatin in Patients with Diabetic Dyslipidemia– A Prospective, Single Centre, Observational Study in Indian Patients
2023
·
Harmanpreet Singh
, Gurpreet Sethi
, et al.
·
Journal of Advances in Medicine and Medical Research
PDF
Show more works
View as search
Works count:
21
Citation count:
129
H-index:
4
I10-index:
2
Year
Topic
Type